Literature DB >> 2226567

Cellular cytotoxicity against autologous hepatocytes in children with different forms of chronic hepatitis B.

K M Keller1, T Poralla, H P Dienes, S Wirth, W Baumann.   

Abstract

Cell-mediated immune reactions play the most important role in the pathogenesis of chronic viral and auto-immune hepatitis. Cellular cytotoxicity (CC) of peripheral blood lymphocytes against autologous hepatocytes isolated from liver biopsies was studied in 29 children with different types of hepatitis B surface antigen (HBsAg)-positive hepatitis. Children with chronic hepatitis B showed higher cytotoxicity than control patients. However, a correlation of cytotoxicity to serum amino-transferases, HBeAg-/Anti-HBe-status, and hepatitis B virus DNA in serum could not be found. Children with a higher percentage of hepatitis B core antigen (HBcAg) expression in their liver tissue presented lower CC values, and vice versa. This supports the hypothesis that virus elimination occurs via T-cell attack against HBcAg expressing hepatocytes. Furthermore, children with a longer duration of chronic hepatitis B had considerably higher cytotoxicity values. Possibly, CC plays a role in perpetuating liver damage after infection with hepatitis B virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226567     DOI: 10.1007/bf02072068

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

Review 1.  Has immunology become important to hepatologists?

Authors:  H C Thomas; A M Lever
Journal:  Prog Liver Dis       Date:  1986

Review 2.  [Morphology, clinical expression and immunopathology of hepatitis B in infancy and childhood (author's transl)].

Authors:  W Baumann; W Arnold; K H Meyer zum Büschenfelde
Journal:  Monatsschr Kinderheilkd       Date:  1980-08       Impact factor: 0.323

3.  Lymphocyte cytotoxicity for autologous hepatocytes.

Authors:  M Mondelli; A L Eddleston
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

4.  Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

Authors:  N V Naumov; M Mondelli; G J Alexander; R S Tedder; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

5.  Cellular cytotoxicity against autologous hepatocytes in chronic hepatitis B--its relationship to the HBeAg/anti-HBe status.

Authors:  T Poralla; T H Hütteroth; M Staritz; K H Meyer zum Büschenfelde
Journal:  Z Gastroenterol       Date:  1985-04       Impact factor: 2.000

6.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors:  C M Chu; Y F Liaw
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

Review 7.  Does the immune response play a role in the pathogenesis of chronic liver disease?

Authors:  M U Mondelli; M Manns; C Ferrari
Journal:  Arch Pathol Lab Med       Date:  1988-05       Impact factor: 5.534

8.  Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease.

Authors:  M Mondelli; G Mieli-Vergani; F Bortolotti; P Cadrobbi; B Portmann; A Alberti; G Realdi; A L Eddleston; A P Mowat
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

9.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.

Authors:  G M Vergani; D Vergani; P J Jenkins; B Portmann; A P Mowat; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

10.  Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency.

Authors:  M Mondelli; G Mieli-Vergani; A L Eddleston; R Williams; A P Mowat
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.